Home
Life Sciences
Diagnostics
Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads

Diagnostics

Summary

Table of Contents

Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads

Publication date: November 2009

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles

» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

As the author lead diagnostic analyst finds, the point of care concept is at a crossroads: the technologies needed to make rapid testing a reality are here. But is healthcare ready?

The drive for wellness and the attention surrounding healthcare reform will surely focus attention on rapid diagnostics. However, according to Shara Rosen, RT, M.B.A., there are many challenges which must be overcome for point of care solutions to fit, and those companies willing to pivot strategies and best adjust to changes in the healthcare marketplace may be rewarded.

This report, Point of Care Diagnostics 2010: Rapid Testing at a Crossroads represents the most current analysis of the role of Point of Care Diagnostics in today's in vitro industry. Other reports have looked at products, companies and market forecasts, as this report does. But in her analysis Shara Rosen takes a bold look into the markets, technologies, and trends in decentralized testing with a special focus on the economics of rapid test use in critical care and emergency medicine.

The report includes:

- Markets for POC Diagnostics (Diabetes, Cardiac markers, Clinical Chemistry/Critical Care, Hematology, Coagulation,
- Drugs of Abuse/Therapeutic Drug Monitoring, Infectious Diseases, Pharmacodiagnostics, Sepsis, Oncology, Women’s health / Pregnancy/Fertility)
- By Venue Revenue Estimates for Hospital POC, Physician POC and Other Venue
- Review of Products in the Market
- Forecasts to 2013
- Markets and Forecasts for Self-Testing (OTC)
- The role of EMR in the Point of Care Market
- Possible Effects of Healthcare Reform
- POLs, Home Monitoring, Alternate Samples and Other Trends
- Successful Strategies of POC Companies
- Profiles of Over 100 Companies Competing in this Market

There are many factors in the growth of POC testing- increasing numbers of diagnosed diabetics, people with cardiovascular disease, and other chronic conditions. It is also expected to play a role in a trend in health care to evaluate provider organizations for quality in care delivery. While this quality imperative is most apparent in pay-for-performance systems, it also provides a framework by which public funds can be used more rationally. This is an especially relevant technology given the U.S. healthcare reform efforts.

All countries are feeling the brunt of aging populations and an increased burden of chronic disease management. Employers and insurance companies are interested in improving the health of customers, and there are some innovative tactics developing in this area. The report is conservative in its predictions and offers a calculated look into the future, based on events currently taking place.

The report offers a quantitative assessment of specific markets in US dollars for 2008 and forecasted out to 2013. These data are provided in order to set the status quo of tests and technologies. However the report concentrates on how these will impact the economics of healthcare over the near term and longer when possible.

The following companies are discussed:

23andMe
3M Health Care
77 Elektronika
A. Menarini
A/C Diagnostics
Abaxis, Inc.
Abbott Diagnostics
ABTECH Scientific
Accumetrics
ACIST Medical
Acrongenomics Inc.
Adeza Biomedical
ADIATEC
Aerscher Diagnostics
AgaMetrix, Inc.
Alfa Scientific
Alfa Wassermann
Alverix Inc.
American Bio Medica
Amic/Ortho
Amnisure International
Animas/J&J
ANP Technologies
Antigen Discovery Inc.
Apollo Hospitals
Arkray
Arrayit Diagnostics
AspenBio Pharma
Astron Clinica
AT First Diagnostic
Audit Diagnostics
Axis-Shield plc
Bayer Diabetes Care
Beckman Coulter
Becton Dickinson
Bedfont Scientific
Biohit Oy
BioIQ
bioLytical Labs
Biomagnetics Diagnostics
Biomerica, Inc.
bioMérieux
Bionime Corp.
Bio-Rad Laboratories
BIOSAFE Medical Technologies
Biosite/Inverness
Boditech Med
BodyTel Scientific
Branan Medical Corp
Burnet Institute
Calypte Biomedical
Careside Medical
Carolina Liquid Chemistries
Celerus Diagnostics
Chelsea Technologies
Chembio Diagnostic
Chempaq A/S
Chemtron Biotech
Cholestech Corp.
Claros Diagnostics
CLX Medical, Inc.
Combimatrix
Common Sense, Ltd.
Commonwealth Labs
Connectyx Technologies
ContraVac, Inc.
Decision Biomarkers
DexCom, Inc.
Diabetech, LP
Diabetes Sentry
Diaglobal GmbH
Diagnostic Devices
Diagnostics for All
Diagnostics for the Real World
Diazyme Laboratories
Digital Bio Tech
Diversa Limited
DNA Direct, Inc.
DNAFORM
DxNA
Echo Therapeutics
EKF-diagnostic GmbH
Enfora
Enigma Diagnostics
Enterix Inc.
Entra Health
Epocal, Inc.
EPS Bio Technology
ESA Biosciences
eScreen, Inc.
ExpressMD Solutions
EyeMarker Systems
Flexsite Diagnostics
Focus Diagnostics
Fora Care
GE Healthcare
GenBio
Gene Smart Wellness
Genexel-Sein Inc.
Gentag Inc.
Genzyme Diagnostics
Global Detection & Reporting
Glucometrics, Inc.
Google, Inc.
Guided Therapeutics
Hai Kang Life Corp.
Hain Lifescience GmbH
HandyLab, Inc.
HealthPia America
HealthPort
Helena Laboratories
Hema Diagnostic Systems
Hema Metrics
HemoCue AB
Hero Network Network
HMM GmbH
Hoana Medical
Home Access Health
Home Diagnostics
Horiba ABX
Idaho Technology
IDenta Corp
Identigene
IDEXX Laboratories
incentaHEALTH LLC
Innovative Biosensors
Instrumentation Laboratory
Insulet Corporation
Integrity Applications
Intel Corporation
International Technidyne
Inverness Medical Innovations
Knome
Lab Express
LifeAssays AB
Lifescan
LifeSign LLC
LifeStat
Lifestream Technologies, Inc.
Lifestyle Choices
Luminex
Luminous Medical
MACHEREY-NAGEL
Masimo Corp
Matritech
M-Biotech
Medical Automation Systems
MedMira Inc.
Medtronic Inc.
Menssana Research, Inc.
Meretek Diagnostics Inc.
Meridian Bioscience
Micromem Technologies
Micronics Inc.
MicroPhage, Inc.
MinuteClinic
Mitsubishi Kagaku Iatron
MP Biomedicals
Multilyte Limited
MycroLab Pty
Nanogen
Nanomix, Inc.
Nanosphere, Inc.
National Jewish Health
Navigenics, Inc.
Network Biosystems
Neuroptix Corp
Nihon Kohden
Noninvasive Medical Tech
Nova Biomedical
OPTI Medical Systems
OraSure Technologies
Orion Diagnostica
OrSense Ltd.
Ortho Clinical Diagnostics
OvumOptics, Inc.
Oxford Biosensors
Oxonica Diagnostics
Phadia AB
Philips Handheld Immunoassays
PlaCor, Inc.
PointCare Technologies
Polymedco
Practice Fusion
PreMD Inc.
PrimeraDx
Probe Scientific Ltd
Prometheus Laboratories
Psynomics
QBC Diagnostics
Qiagen
Q-linea
Quadraspec
QualSec, Inc
QuantRx Biomedical Corporation
Quidel Corp
Quotient Diagnostics
Radiometer A/S
Raman spectroscopy
Rapid Pathogen Screening
Rennesens GmbH
Response Biomedical
Rite Aid
Roche Diagnostics
Royal Philips Electronics
Safeway, Inc.
Screening Devices Canada
SEMOFS
Sentinel Bioactive Paper Network
SeraCare Life Sciences
Serotec
Siemens Healthcare Diagnostics
SIENCO
Smiths Detection
Smiths Medical MD
Soar BioDynamics
Solei Systems, Inc
Solianis Monitoring
SpectraScience, Inc.
Sphere Medical Ltd.
SpheroSense Technologies
Stanbio Laboratory
StatSure Diagnostic Systems
STD Test Express
STMicroelectronics
Synova Healthcare
Sysmex Corp
T2 Biosystems
Taidoc Technology
TelCare
Telus Corporation
Textronics, Inc.
Thermo Fisher Scientific
Tosoh Corp
Trinity Biotech
TwistDx, Ltd.
Tyrian Diagnostics
UnitedHealth Group
Veralight, Inc.
Veredus Laboratories
VeriChip Corporation
Via Medical Corp
Vital Diagnostics
Vivacta Limited
Walgreens
Wal-Mart Stores
Webahn Inc.
Ypsomed

Diagnostics Industry in the United States

CHAPTER ONE: EXECUTIVE SUMMARY: Scope and Methodology; Size and Growth of the Market
CHAPTER TWO: INTRODUCTION: Miniaturization, Digitization and Informatics; The pros and cons of POC testing; Point of View
CHAPTER THREE: ECONOMICS, EMR AND HEALTHCARE REFORM: Healthcare Reform; POC and Clinical Outcomes Management; POC’s Unmet Need
CHAPTER FOUR: TECHNOLOGY AND INDUSTRY TRENDS: Background; The search for non-invasive tools; The Wireless Revolution; Lab-on-a chip
CHAPTER FIVE: VENUES FOR POC TESTING: POC Testing in the Hospital; POL and Clinic Testing
CHAPTER SIX: MARKET ANALYSIS: Market Overview; Prognosis for POC growth; Technological Challenges; Market and Forecasts; POC in world markets; HIV/AID; Market for Rapid Flu Testin; The Major Players; Licenses and Distribution Agreements
CHAPTER SEVEN: POC TEST SEGMENTS: Diabetes Testing - Blood Glucose Monitoring (BGM); Blood Glucose Self-Testing; Blood Glucose Testing by Professionals; Diabetes Testing - Glycated Hemoglobin; Cardiovascular Diagnostics; Cardiac Markers (AMI enzymes); Cholesterol/Lipid Panels; Clinical Chemistry/Critical Care; Hemoglobin Testing for Anemia; Hematology; Coagulation; Drugs of Abuse/Therapeutic Drug Monitoring; Allergy; Infectious Diseases; Pharmacodiagnostics; Sepsis; Oncology; Women’s Health / Pregnancy/Fertility; Emerging Tests and Technologies; Commercial Outlook
CHAPTER EIGHT: COMPANY PROFILES MAJOR COMPANIES: Abbott Diagnostics; ARKRAY, Inc.; Bayer Diabetes Care; Beckman Coulter Inc.; Becton, Dickinson and Company (BD); bioMerieux Inc.; Bio-Rad Laboratories Inc.; GE Healthcare; Instrumentation Laboratory; Inverness Medical Innovations; Lifescan Inc.; Nova Biomedical; Ortho Clinical Diagnostics (OCD); Qiagen N.V.; Quidel Corporation; Radiometer A/S; Roche Diagnostics; Siemens Healthcare Diagnostics; Sysmex Corporation; TOSOH Corporation
‘New Frontier’ POC COMPANIES: 3M Health Care; 77 Elektronika Kft.; Abaxis, Inc.; A/C Diagnostics; Accumetrics; ACIST Medical Systems, Inc.; AgaMetrix, Inc.; Alfa Wassermann Diagnostic Technologies, LLC (AWDT); American Bio Medica Corp; Audit Diagnostics; Axis-Shield plc; Biohit Oy; BioIQ; Biomerica, Inc.; Biosite Incorporated; B.R.A.H.M.S. AG; Calypte Biomedical Corporation; Chembio Diagnostic Systems, Inc.; Chempaq A/S; Cholestech Corporation; Concateno plc; DexCom, Inc.; Diabetech, LP; Diazyme Laboratories; EKF-diagnostic GmbH; ESA Biosciences Inc.; Hain Lifescience GmbH; HandyLab, Inc.; Helena Laboratories USA; Hema Diagnostic Systems (HDS); HemoCue AB; HemoSense, Inc.; Home Diagnostics, Inc.; Horiba ABX S.A.; Insulet Corporation; International Technidyne Corp (ITC); Masimo Corporation; Matritech; Medical Automation Systems, Inc.; MedMira Inc.; Medtronic Inc.; A. Menarini Diagnostics; Meridian Bioscience; MP Biomedicals LLC; Nanosphere, Inc.; OPTI Medical Systems, Inc.; OraSure Technologies, Inc.; Phadia AB; Philips Handheld Immunoassays; Polymedco, Inc.; QBC Diagnostics, Inc.; Response Biomedical Corp; Serotec (AbD Serot; Smiths Medical MD, Inc. (formerly Deltec, Inc.); Stanbio Laboratory; Taidoc Technology Corp.; Trinity Biotech plc; Via Medical Corporation; Vital Diagnostics
Other Players: Acrongenomics Inc.; Alfa Scientific Designs, Inc.; Amic AB; Astron Clinica; AspenBio Pharma, Inc.; AT First Diagnostic, LLC; bioLytical Laboratories Inc.; Biomagnetics Diagnostics Corporation; Bionime Corporation; BodyTel Scientific, Inc.; Burnet Institute; Celerus Diagnostics; Chelsea Technologies Group Ltd; Claros Diagnostics; CLX Medical, Inc.; ContraVac, Inc.; Decision Biomarkers Inc.; Diabetes Sentry Products Inc.; Diaglobal GmbH; Diagnostic Devices, Inc.; Diagnostics for All (DFA); Diagnostics for the Real World (DRW); Digital Bio Technology/ InCyto; Diversa Limited (formerly Ambri Ltd.); DNAFORM; DxNA; Echo Therapeutics, Inc. (previously Sontra Medical); Enigma Diagnostics Limited; Enterix Inc.; Entra Health Systems; Epocal, Inc.; EUMED Biotechnology Co. Ltd.; eScreen, Inc.; EyeMarker Systems, Inc.; Flexsite Diagnostics, Inc.; Fora Care; GenBio; Gene Smart Wellness; Gentag Inc.; Glucometrics, Inc.; Guided Therapeutics, Inc.; Hai Kang Life Corporation; HealthPia America; Heidelberger-Medical-Marketing GmbH (HMM GmbH); Hema Metrics; Hoana Medical, Inc.; Idaho Technology, Inc.; Identa Corporation; Identigene; Innovative Biosensors, Inc.; Integrity Applications Ltd.; Intel Corporation; LifeAssays AB; LifeSign LLC; Lifestyle Choices Ltd; Luminous Medical, Inc.:; M-Biotech; Menssana Research, Inc.; Micromem Technologies Inc.; Micronics Inc.; MicroPhage, Inc.; Multilyte Limited; MycroLab Pty Ltd.; Nanomix, Inc.; National Jewish Health; Network Biosystems; Neuroptix Corporation; Noninvasive Medical Technologies, Inc.; OrSense Ltd.; OvumOptics, Inc.; Oxonica Diagnostics; PlaCor, Inc.; PointCare Technologies; Probe Scientific Ltd; Prometheus Laboratories Inc.; Q-linea; Quadraspec; QualSec, Inc; QuantRx Biomedical Corporation; Quotient Diagnostics; Rapid Pathogen Screening; Rennesens GmbH; Screening Devices Canada, Inc.; Sentinel Bioactive Paper Network; Sphere Medical Ltd.; SIENCO; Smiths Detection; Solei Systems, Inc.; Solianis Monitoring AG; SpheroSense Technologies Inc.; STD Test Express; Surface Enhanced Micro Optical Fluidic Systems; T2 Biosystems, Inc.; TwistDx, Ltd.; Veralight, Inc.; Veredus Laboratories Pte; VeriChip Corporation; Vivacta Limited
LIST OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY: Table 1-1: Exchange Rate Fluctuations, 2005-2008; Table 1-2: POC Sales by Test Category (OTC and POC), Worldwide 2008-2013
CHAPTER FOUR: TECHNOLOGY AND INDUSTRY TRENDS: Table 4-1: Selected Non-Invasive Testing Innovations; Table 4-2: Selected disease markers in exhaled breath; Table 4-3: Selected POC Wireless Innovations, 2008-2009; Table 4-4: RALS connected POC systems, 2009; Table 4-5: Selected biochip and biosensor innovations, 2009
CHAPTER FIVE: VENUES FOR POC TESTING: Figure 5-1: Venues for POC Testing (Hospital, Physician, Other); Table 5-1: POC Test Sales in the Hospital Sector (Critical Care, Glucose, Cardiac Markers, Infectious Diseases, Coagulation, Hematology, Drugs of Abuse, Cholesterol, Pregnancy, Urinalysis), 2008; Table 5-2: POC Test Sales in the POL Sector (Glucose, Cholesterol, HbA1c, Coagulation, Hematology, Chemistry/Immunoassays, Infectious Diseases, Fecal Occult Blood, Pregnancy, Cardiac Markers, Oncology, Urinalysis, Drugs of Abuse), 2008; Table 5-3: Selected Small Footprint Chemistry Systems, 2009; Table 5-4: Selected Small Footprint Hematology Systems, 2009; Table 5-5: Selected New Small Footprint Immunoassay Systems, 2009; Table 5-6: POC Test Sales in Other Care Venues (Glucose, Cholesterol, Drugs of Abuse, Fecal Occult Blood, Infectious Diseases, Urinalysis, Coagulation), 2008; Table 5-7: Selected self-test innovations, 2008-2009
CHAPTER SIX: MARKET ANALYSIS: Table 6-1: OTC/Self Test Sales by Test Category (Glucose, Pregnancy, Coagulation, Fecal Occult Blood, Drugs of Abuse, HbA1c, HIV, Cholesterol, Other) Worldwide 2008 and 2013; Figure 6-1: Breakout of Non-Glucose Self-Testing; Figure 6-2: Professional POC Testing Market by Test Category; Table 6-2: Professional Point of Care Testing Market by Test Category (Glucose, Critical Care, Cardiac Markers, Infectious Diseases, Cholesterol/Lipids, Coagulation, Hematology, HbA1c, Chemistry/Immunoassays, Fecal Occult Blood, Drugs of Abuse, Pregnancy, Urinalysis, Onocology, Other) 2008 and 2013; Figure 6-3: Professional POC Testing Market by Test Category; Table 6-3: POC Test Sales by Region (US, Europe, Asia, ROW), 2008-2013; Table 6-4: POC Test Revenues of Selected IVD Companies, $ million, estimated; Table 6-5: Selected Market Expansion Deals in POC testing, 2008-2009
CHAPTER SEVEN: POC TEST SEGMENTS: Table 7-1: World Glucose Monitoring Sales, by Company, 2005 - 2008; Table 7-2: Selected Glucose Meter Innovations, 2008-2009; Table 7-3: Selected Wireless Enabled Blood Glucose Monitors, 2009; Table 7-4: Selected Continuous BGM Sales by Company, 2008; Table 7-5: Selected Continuous Blood Glucose Systems, 2009; Table 7-6: Glucose Meters that use GDH-PQQ technology; Table 7-7: Selected POC HbA1c Devices, 2009; Table 7-8: Worldwide Sales, POC CVD markers (Cholesterol -Professional, Cholesterol OTC, AMI Enzymes), 2008-2013; Table 7-9: Selected POC Hematology Systems, 2009; Table 7-10: World POC Coagulation Sales(PT-Professional, PT OTC, ACT), 2008 (million); Table 7-11: Selected CLIA Waived PT Devices; Table 7-12: Selected Rapid HIV Tests on the Market; Table 7-13: Selected Rapid Infectious Disease Test Innovations; Table 7-14: Selected Women’s Health OTC Tests; Table 7-15: Selected POC Platform Innovations, 2008/2009

Talk to Alison

00 1 718 618 48 97

Send Your Request

Follow

Add to circles Subscribe to our RSS feeds!

Diagnostics Industry in the United States : Latest Reports

In Vitro Diagnostics - A Global Market Overview

$ 4 500
Industry report
May 2012
by Industry Experts

`The In Vitro Diagnostic (IVD) industry has been confronting a range of issues, such as regulations, industry consolidation, reforms in healthcare, low level of technological innovations and ever-changing ...

United States In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

$ 2 500
Industry report
January 2012
by Global Data

United States In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture Summary ...

HIV-AIDS Testing Markets

$ 3 400
Industry report
January 2012
by TriMark Publications

There are an estimated 33.3 million people living with HIV (the virus which causes AIDS) worldwide and approximately 2.6 million people are newly-infected each year. While the Asian and African regions ...

Point Of Care Diagnostic Testing Sector Tr ...

November 2011 $ 3 400

Drug Discovery And Development: Corgenix, ...

October 2011 $ 750

In Vitro Diagnostic: Epinex Diagnostics In ...

October 2011 $ 750

Drug Discovery And Development: Geneex, In ...

October 2011 $ 750

Global Automated And Rapid Microbiological ...

October 2011 $ 4 500

Molecular Diagnostics Markets

July 2011 $ 3 400

Rapid Tests And Point Of Care Market To 20 ...

February 2012 $ 3 500

More Reports:

Diagnostics in France (242)

Diagnostics in Germany (239)

Diagnostics in India (66)

Diagnostics in Italy (238)

Diagnostics in Japan (257)

Diagnostics in Spain (225)

Diagnostics in the United Kingdom (81)

Diagnostics in the United States (390)

Company Reports

Abbott Laboratories

Siemens Healthcare Diagnostics

Bio-Rad Laboratories

Beckman Coulter Inc.

Roche Diagnostics

Bio-Rad Laboratories Inc.

Gen-Probe Inc.

Danaher Corp.

Gems Sensors And Controls

Siemens AG

Diagnostics Industry in the United States : Latest Downloads

In Vitro Diagnostic : Innovation and Technology Trends

Industry report
July 2011
8 pages

Global In Vitro Diagnostic : Innovation and Technology Trends

Industry report
April 2012
25 pages

... David kelso oak ridge april 20, 2012 in vitro diagnostic platforms for the developing world center for innovation in global health technologies industry academia philanthropy ...

In Vitro Diagnostic Sector

Industry report
April 2012
42 pages

... Cancer markers, cardiac markers, genetic tests all ivds not in a, c or d e.G. Vitamin b12, poc, urine test strips. Similar to general ivds no ivdd equivalent similar to annex ii list b similar ...